| Literature DB >> 26085214 |
Abstract
Among all the E2 ubiquitin-conjugating enzymes, Ubc13, which heterodimerizes with Uev1a, specifically mediates lysine 63 (K63)-linked protein polyubiquitylation, a process that does not lead to proteasomal degradation of its substrates. Instead, it plays a key role in signal transduction. Numerous roles of Lys63-linked polyubiquitylation in immune responses have emerged, indicating the importance of this regulatory strategy. Here, we summarize some of the signaling pathways that depend on Lys63-linked polyubiquitylation during innate and adaptive immune responses, with a focus on the underlying molecular mechanisms. In addition, we describe how Ubc13 itself is regulated and outline its function in transforming growth factor β signaling. We discuss the current progress in pharmacological targeting of Ubc13 in inflammatory and autoimmune diseases as well as cancer therapy.Entities:
Keywords: K63-polyubiquitylation; Ubc13; adaptive immunity; innate immunity
Mesh:
Substances:
Year: 2015 PMID: 26085214 DOI: 10.1111/imr.12310
Source DB: PubMed Journal: Immunol Rev ISSN: 0105-2896 Impact factor: 12.988